Impressive
enough to
fill a room.
Streamlined
enough
to leave it
almost empty.
Presenting TENEO
™
, the first excimer platform to earn FDA approval in 17 years.
It's purposeful and purpose-built design allows you to:
Get in touch at:
bauschsurgical.com /refractive /teneo
Please see reverse side for Indiciations
and Impor tant Safety Information
T E N .0 0 47.U SA . 24
* Among flying spot lasers
** Based upon calculation using an Optical Zone of 6mm and a standard myopic treatment (
PROSCAN mode )
Get exceptional outcomes
No nomogram required
Free up space
With the smallest footprint in the U.S.
Streamline set-up
With a customizable GUI touchscreen
Experience speed
Fastest eye-tracker* and ablation time**
in the U.S.
©2024 Bausch + Lomb
